Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Intec Parent's share price for the quarter that ended in Mar. 2021 was $17.48. Intec Parent's Shares Outstanding (EOP) for the quarter that ended in Mar. 2021 was 1.13 Mil. Therefore, Intec Parent's market cap for the quarter that ended in Mar. 2021 was $19.68 Mil.
Intec Parent's quarterly market cap
declined
from Sep. 2020 ($19.87 Mil) to Dec. 2020 ($14.91 Mil) but then
increased
from Dec. 2020 ($14.91 Mil) to Mar. 2021 ($19.68 Mil).
Intec Parent's annual market cap
declined
from Dec. 2018 ($250.58 Mil) to Dec. 2019 ($18.11 Mil) and
declined
from Dec. 2019 ($18.11 Mil) to Dec. 2020 ($14.91 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Intec Parent's Enterprise Value for Today is $17.75 Mil.
Intec Parent Market Cap Historical Data
The historical data trend for Intec Parent's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Intec Parent's Market Cap
For the Biotechnology subindustry, Intec Parent's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intec Parent's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Intec Parent's Market Cap distribution charts can be found below:
* The bar in red indicates where Intec Parent's Market Cap falls into.
Intec Parent Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Intec Parent's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intec Parent (NAS:NTEC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Intec Parent Market Cap Related Terms
Thank you for viewing the detailed overview of Intec Parent's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Intec Parent Inc, formerly Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. The company is focused on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NTEC has been successfully added to your 